While many see Elias Zerhouni's attempt to make his support for new investigators permanent NIH policy a good thing, DrugMonkey doesn't think the issue of who-gets-what is so clear-cut. He says it's the inherent bias in peer review that needs to be changed, and that Band-Aid solutions like the so-called affirmative action favoring young or first-time grant applicants are masking the real problem. "How so?

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.